Revenio Group Oyj (REG1V):企業の財務・戦略的SWOT分析

◆英語タイトル:Revenio Group Oyj (REG1V) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME241719FSA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フィンランド
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Revenio Group Oyj (REG1V) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Revenio Group Oyj (Revenio) is a provider of health tech screening devices that focus on ophthalmic diagnostic solutions. The company focuses on early detection of glaucoma, asthma, skin cancer and macular degeneration. The company’s major products include devices for detecting age-related eye diseases which include glaucoma, diabetic retinopathy, macular degeneration and cataracts. Revenio offers its products to ophthalmologists, opticians and optometrists. The company has operations in Europe, America, and Asia. Revenio is headquartered in Vantaa, Finland.

Revenio Group Oyj Key Recent Developments

Oct 22,2020: Revenio Group : Interim report, January 1 – September 30, 2020
Oct 21,2020: Revenio Group board of directors established a nomination and remuneration committee
Aug 06,2020: Revenio Group Corporation: Half-year financial report, January 1 – June 30, 2020
Apr 22,2020: Revenio Group : Interim report, January 1 – March 31, 2020
Mar 31,2020: Jouni Toijala appointed as the CEO of Revenio Group

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Revenio Group Oyj – Key Facts
Revenio Group Oyj – Key Employees
Revenio Group Oyj – Key Employee Biographies
Revenio Group Oyj – Major Products and Services
Revenio Group Oyj – History
Revenio Group Oyj – Company Statement
Revenio Group Oyj – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Revenio Group Oyj – Business Description
Geographical Segment: Finland
Performance
Geographical Segment: Other Europe
Performance
Geographical Segment: Others
Performance
R&D Overview
Revenio Group Oyj – Corporate Strategy
Revenio Group Oyj – SWOT Analysis
SWOT Analysis – Overview
Revenio Group Oyj – Strengths
Revenio Group Oyj – Weaknesses
Revenio Group Oyj – Opportunities
Revenio Group Oyj – Threats
Revenio Group Oyj – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Revenio Group Oyj, Medical Equipment, Deals By Year, 2014 to YTD 2020
Revenio Group Oyj, Medical Equipment, Deals By Type, 2014 to YTD 2020
Revenio Group Oyj, Recent Deals Summary
Section 5 – Company’s Recent Developments
Oct 22, 2020: Revenio Group : Interim report, January 1 – September 30, 2020
Oct 21, 2020: Revenio Group board of directors established a nomination and remuneration committee
Aug 06, 2020: Revenio Group Corporation: Half-year financial report, January 1 – June 30, 2020
Apr 22, 2020: Revenio Group : Interim report, January 1 – March 31, 2020
Mar 31, 2020: Jouni Toijala appointed as the CEO of Revenio Group
Nov 25, 2019: Revenio Group Corporation – Changes in management
Aug 15, 2019: Revenio Group : Half-year financial report
Apr 16, 2019: Revenio Group: Interim Report January 1- March 31, 2019
Apr 15, 2019: Revenio Group: Mikko Moilanen appointed as Revenio’s CEO
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Revenio Group Oyj, Key Facts
Revenio Group Oyj, Key Employees
Revenio Group Oyj, Key Employee Biographies
Revenio Group Oyj, Major Products and Services
Revenio Group Oyj, History
Revenio Group Oyj, Subsidiaries
Revenio Group Oyj, Key Competitors
Revenio Group Oyj, Ratios based on current share price
Revenio Group Oyj, Annual Ratios
Revenio Group Oyj, Annual Ratios (Cont...1)
Revenio Group Oyj, Annual Ratios (Cont...2)
Revenio Group Oyj, Interim Ratios
Revenio Group Oyj, Medical Equipment, Deals By Year, 2014 to YTD 2020
Revenio Group Oyj, Medical Equipment, Deals By Type, 2014 to YTD 2020
Revenio Group Oyj, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Revenio Group Oyj (REG1V):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Otonomy Inc (OTIC):製薬・医療:M&Aディール及び事業提携情報
    Summary Otonomy Inc (Otonomy) develops and markets treatments for diseases and disorders of the ear. The company’s Otiprio is the US FDA approved ciprofloxacin otic suspension indicated during tympanostomy tube placement surgery in pediatric patients. Its pipeline portfolio encompasses Otividex for …
  • BioMarin Pharmaceutical Inc.:企業の戦略・SWOT・財務分析
    BioMarin Pharmaceutical Inc. - Strategy, SWOT and Corporate Finance Report Summary BioMarin Pharmaceutical Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • SEEK Limited:企業の戦略・SWOT・財務情報
    SEEK Limited - Strategy, SWOT and Corporate Finance Report Summary SEEK Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Ws Atkins Ltd
    Ws Atkins Ltd - Strategy, SWOT and Corporate Finance Report Summary Ws Atkins Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • F.N.B. Corporation:企業のM&A・事業提携・投資動向
    F.N.B. Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's F.N.B. Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Takara Bio Inc (4974):医療機器:M&Aディール及び事業提携情報
    Summary Takara Bio Inc (Takara), a subsidiary of Takara Holdings Inc, is a biotechnology company that develops, manufactures and distributes biotechnology research reagents and equipments for life sciences research. The company sells gene amplification system and offers scientific instruments. It of …
  • Exelon Generation Company LLC:発電所・企業SWOT分析
    Exelon Generation Company LLC - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • PricewaterhouseCoopers LLP (UK):企業の戦略的SWOT分析
    PricewaterhouseCoopers LLP (UK) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • CAT Telecom Public Co Ltd:企業の戦略的SWOT分析
    CAT Telecom Public Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Collins Foods Ltd (CKF):企業の財務・戦略的SWOT分析
    Collins Foods Ltd (CKF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • BerryPharma AG:企業の戦略・SWOT・財務情報
    BerryPharma AG - Strategy, SWOT and Corporate Finance Report Summary BerryPharma AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Petroleum Development Oman LLC:企業の戦略的SWOT分析
    Petroleum Development Oman LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • EnQuest PLC (ENQ):企業の財務・戦略的SWOT分析
    Summary EnQuest Plc (EnQuest) is an independent oil and gas exploration and production company. The company carries out operational and redevelopment interests in onshore and offshore oil and gas fields in the UK North Sea and Malaysia. Its operated assets include Thistle and Deveron, Heather and Br …
  • Audentes Therapeutics Inc (BOLD)-製薬・医療分野:企業M&A・提携分析
    Summary Audentes Therapeutics Inc (Audentes) is a biotechnology company that focuses on the development and commercialization of gene therapy products for serious and life-threatening rare diseases. The company’s pipeline products include AT132, intended for the treatment of X-linked myotubular myop …
  • Ssangyong Cement Industrial Co., Ltd.:企業の戦略・SWOT・財務情報
    Ssangyong Cement Industrial Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Ssangyong Cement Industrial Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Korea Gas Corp (036460)-石油・ガス分野:企業M&A・提携分析
    Summary Korea Gas Corp (KOGAS) is a vertically integrated natural gas company active in upstream midstream and downstream segments of natural gas industry. It explores, produces and distributes natural gas. The company also purifies and sells by-products; imports and exports natural gas and liquefie …
  • Humana Inc.:企業のM&A・事業提携・投資動向
    Humana Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Humana Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • The University of New South Wales-製薬・医療分野:企業M&A・提携分析
    Summary The University of New South Wales (UNSW Australia) is an academic university that offer research and education services. The university’s educational services include fine arts education, design, media arts, art and design, art history, theory and art administration, social sciences, enginee …
  • Outotec Oyj:企業の戦略・SWOT・財務情報
    Outotec Oyj - Strategy, SWOT and Corporate Finance Report Summary Outotec Oyj - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Carmat SAS (ALCAR):企業の財務・戦略的SWOT分析
    Summary Carmat SAS (Carmat) is a medical equipment company that provides artificial organs. The company provides development of innovative artificial organs, artificial heart and other vital organs, among others. Carmat artificial heart products consist of an implantable heart. The company offers co …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆